Koyfin Home > Directory > Health Care > Pieris Pharma > Enterprise Value

Pieris Pharma Enterprise Value Chart (PIRS)

Pieris Pharma annual/quarterly Enterprise Value from 2014 to 2020.
  • Pieris Pharma Enterprise Value for the quarter ending November 11, 2020 was $92m a 4.28% increase of 4m year over year
  • Pieris Pharma Enterprise Value for the last 12 months ending November 11, 2020 was $92m a 4.28% increase of 4m year over year
  • Pieris Pharma Annual Enterprise Value for 2020 was $92m a 2.45% increase of 2m from 2019
  • Pieris Pharma Annual Enterprise Value for 2020 was $89m a 3.76% increase of 3m from 2019
  • Pieris Pharma Annual Enterprise Value for 2020 was $86m a -1.95% decrease of -2m from 2019
Other Valuation Metrics:
  • Pieris Pharma Market Cap for the quarter ending March 03, 2018 was $367m a 40.67% increase of 149m year over year
  • Pieris Pharma Price / Book for the quarter ending March 03, 2018 was 26.65 a 54.66% increase of 14.57 year over year
View Chart On Koyfin

Quarterly PIRS Enterprise Value Data

11/2020$92m
11/2020$89m
11/2020$86m
11/2020$88m
11/2020$91m
11/2020$93m
11/2020$87m
11/2020$82m
11/2020$84m
11/2020$92m

Annual PIRS Enterprise Value Data

2020$92m
2020$89m
2020$86m
2020$88m
2020$91m
2020$93m
2020$87m
2020$82m
2020$84m
2020$92m